The state of Connecticut currently has 17 active clinical trials seeking participants for Hypertension research studies. These trials are conducted in various cities, including New Haven, Hartford, Farmington and Stamford.
AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension
NCT04499248
Recruiting
This is a multicenter, open-label, dose escalation (Cohort 1) to masked, randomized, parallel-groups (Cohort 2) and (Cohort 3) study to evaluate the safety and efficacy of AGN-193408 SR in participants with open-angle glaucoma or ocular hypertension
Gender:
All
Ages:
18 years and above
Trial Updated:
04/11/2024
Locations: Connecticut Eye Consultants P.C. /ID# 235862, Danbury, Connecticut
Conditions: Open-angle Glaucoma, Ocular Hypertension
Register for Updates
Chronotherapy in Children With Chronic Kidney Disease
NCT05353335
Recruiting
This is a pilot, crossover trial in which the investigator will determine if retiming of one anti-hypertensive medication from morning to evening can effectuate normal blood pressure dipping patterns in children and adolescents with chronic kidney disease.
Gender:
All
Ages:
Between 6 years and 18 years
Trial Updated:
02/27/2024
Locations: Yale New Haven Children's Hospital/Yale New Haven Health, New Haven, Connecticut
Conditions: Chronic Kidney Diseases, Hypertension
Register for Updates
MRCT Evaluating NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension
NCT04630808
Recruiting
The objective of this clinical study is to evaluate the safety and efficacy of NCX 470 Ophthalmic Solution in lowering intraocular pressure (IOP) in subjecs with ocular hypertension or open-angle glaucoma. Subjects will be randomized in a 1:1 ratio to NCX 470 0.1% or to latanoprost 0.005% to be administered to both eyes once daily in the evening for up to 12 months.
Gender:
All
Ages:
Between 18 years and 84 years
Trial Updated:
02/23/2024
Locations: Nicox Clinical Site, Danbury, Connecticut
Conditions: Open Angle Glaucoma, Ocular Hypertension
Register for Updates
A Phase 2a Study of LAM-001 for the Treatment of Pulmonary Hypertension
NCT05798923
Recruiting
This is a clinical trial to assess the efficacy and safety of LAM-001 as an add-on therapy for the treatment pulmonary hypertension.
Gender:
All
Ages:
18 years and above
Trial Updated:
10/02/2023
Locations: Yale New Haven Hospital, New Haven, Connecticut
Conditions: Pulmonary Hypertension
Register for Updates
Trauma-informed Approach to Timely Detection and Management of Early Postpartum Hypertension
NCT05884190
Recruiting
The investigators primary project goal is to improve clinical outcomes, including mental health outcomes, among postpartum at-risk women experiencing health disparities by increasing awareness, detection, and timely care of postpartum hypertension, mental health and cardiovascular complications. The investigators will accomplish this by comparing the effectiveness of two multi-component multi-level healthcare delivery models focused on early detection and control of postpartum hypertension and t... Read More
Gender:
Female
Ages:
18 years and above
Trial Updated:
08/31/2023
Locations: Yale New Haven Hospital, New Haven, Connecticut
Conditions: Postpartum Hypertension
Register for Updates